VR Adviser’s ESSA Pharma EPIX Stock Holding History

VR Adviser’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-625,754	Closed	-$17.9M	–	29
2021 Q2	$17.9M	Hold	625,754	–	–	2.17%	16
2021 Q1	$18.2M	Buy	+625,754	New	+$14.5M	1.97%	16

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VR Adviser's EPIX Position: Q3 2021 in Review

VR Adviser sold out of ESSA Pharma (EPIX) in Q3 2021, closing a stake of 625,754 shares — an estimated $17.9M sold.

VR Adviser first reported a position in EPIX in Q1 2021 and held it in 2 quarters. The position peaked at $18.2M in Q1 2021. 75 funds tracked by Wall St. Rank hold EPIX as of Q3 2021.

VR Adviser reported no remaining ESSA Pharma position as of Q3 2021 after selling out during the quarter.
VR Adviser sold 625,754 ESSA Pharma shares in Q3 2021, an estimated $17.9M.
VR Adviser first reported a position in ESSA Pharma in Q1 2021 and held it in 2 quarters.
VR Adviser's ESSA Pharma position peaked at $18.2M in Q1 2021.
75 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2021.

Based on VR Adviser's 13F filing for Q3 2021, filed 15 Nov 2021.